Cerner Corp. Now Covered by Hilliard Lyons (CERN)
Investment analysts at Hilliard Lyons began coverage on shares of Cerner Corp. (NASDAQ:CERN) in a note issued to investors on Monday, AnalystRatings.Net reports. The firm set a “buy” rating on the stock.
The analysts wrote, “We believe Cerner has a technological competitive advantage due to the company’s sole focus on health care information technology, and its product offering size and scale within the industry. Through this competitive advantage along with government mandates and positive industry trends Cerner has the potential to gain market share, in our opinion. New growth trends beyond Cerner’s core Electronic Health Record (EHR) system, Millennium, include physician practice management solutions, population health management and revenue cycle management software & services.”
Cerner Corp. (NASDAQ:CERN) traded up 1.52% during mid-day trading on Monday, hitting $48.10. The stock had a trading volume of 596,744 shares. Cerner Corp. has a 52 week low of $33.82 and a 52 week high of $50.85. The stock has a 50-day moving average of $48.99 and a 200-day moving average of $47.06. The company has a market cap of $16.503 billion and a price-to-earnings ratio of 38.52.
Cerner Corp. (NASDAQ:CERN) last announced its earnings results on Thursday, July 25th. The company reported $0.34 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.34. The company had revenue of $707.60 million for the quarter, compared to the consensus estimate of $725.71 million. During the same quarter in the previous year, the company posted $0.59 earnings per share. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. On average, analysts predict that Cerner Corp. will post $1.41 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at KeyCorp initiated coverage on shares of Cerner Corp. in a research note to investors on Tuesday, August 13th. They set a “buy” rating and a $60.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Cerner Corp. in a research note to investors on Tuesday, July 30th. They now have a $51.00 price target on the stock. Finally, analysts at Lazard Capital Markets raised their price target on shares of Cerner Corp. from $54.00 to $55.00 in a research note to investors on Friday, July 26th. They now have a “buy” rating on the stock.
One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $86.65.
Cerner Corporation is a supplier of healthcare information technology solutions, services, devices and hardware.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.